Studies have shown that ANO1 overexpression in HNSCC activates the mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) signaling pathway, promoting tumor proliferation and correlating with poor prognosis (143). This evidence concerns the gene ANO1 and neoplasm.